<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34946884</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Juvenile Amyotrophic Lateral Sclerosis: A Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1935</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes12121935</ELocationID><Abstract><AbstractText>Juvenile amyotrophic lateral sclerosis (JALS) is a rare group of motor neuron disorders with gene association in 40% of cases. JALS is defined as onset before age 25. We conducted a literature review of JALS and gene mutations associated with JALS. Results of the literature review show that the most common gene mutations associated with JALS are <i>FUS</i>, <i>SETX</i>, and <i>ALS2</i>. In familial cases, the gene mutations are mostly inherited in an autosomal recessive pattern and mutations in <i>SETX</i> are inherited in an autosomal dominant fashion. Disease prognosis varies from rapidly progressive to an indolent course. Distinct clinical features may emerge with specific gene mutations in addition to the clinical finding of combined upper and lower motor neuron degeneration. In conclusion, patients presenting with combined upper and lower motor neuron disorders before age 25 should be carefully examined for genetic mutations. Hereditary patterns and coexisting features may be useful in determining prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehky</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6421-505X</Identifier><AffiliationInfo><Affiliation>EMG Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS2</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">SETX</Keyword><Keyword MajorTopicYN="N">familial amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34946884</ArticleId><ArticleId IdType="pmc">PMC8701111</ArticleId><ArticleId IdType="doi">10.3390/genes12121935</ArticleId><ArticleId IdType="pii">genes12121935</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Z.J., Lin H.X., Liu G.L., Tao Q.Q., Ni W., Xiao B.G., Wu Z.Y. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin. Genet. 2017;92:267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal A., Shashiraj Juvenile amyotrophic lateral sclerosis. Indian J. Pediatr. 2006;73:225&#x2013;226. doi: 10.1007/BF02825486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02825486</ArticleId><ArticleId IdType="pubmed">16567917</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Brunet F., Dupre N., Chrestian N. The Occurrence of FUS Mutations in Pediatric Amyotrophic Lateral Sclerosis: A Case Report and Review of the Literature. J. Child. Neurol. 2020;35:556&#x2013;562. doi: 10.1177/0883073820915099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073820915099</ArticleId><ArticleId IdType="pubmed">32281455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacem I., Sghaier I., Bougatef S., Nasri A., Gargouri A., Ajroud-Driss S., Gouider R. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotroph. Lateral Scler. Front. Degener. 2020;21:131&#x2013;139. doi: 10.1080/21678421.2019.1704012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1704012</ArticleId><ArticleId IdType="pubmed">31858811</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.M., Masson G.L. Genetics of amyotrophic lateral sclerosis: A review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001;29:166&#x2013;173. doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A., Just W., Rosenbohm A., Muller K., Marroquin N., Goebel I., Hogel J., Thiele H., Altmuller J., Nurnberg P., et al. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol. Aging. 2015;36:3117.e3111&#x2013;3117.e3116. doi: 10.1016/j.neurobiolaging.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.005</ArticleId><ArticleId IdType="pubmed">26362943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Rev. Neurol. 2021;177:333&#x2013;340. doi: 10.1016/j.neurol.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.06.010</ArticleId><ArticleId IdType="pubmed">33036763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Che C.H., Feng S.Y., Fang X.Y., Huang H.P., Liu C.Y. Novel FUS mutation Y526F causing rapidly progressive familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2021;22:73&#x2013;79. doi: 10.1080/21678421.2020.1797815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1797815</ArticleId><ArticleId IdType="pubmed">32720527</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., Gunther R., van der Kooi A.J., Aronica E., Hubers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayanagi K., Sato M., Furuta N., Makioka K., Ikeda Y. Juvenile-onset Sporadic Amyotrophic Lateral Sclerosis with a Frameshift FUS Gene Mutation Presenting Unique Neuroradiological Findings and Cognitive Impairment. Intern. Med. 2016;55:689&#x2013;693. doi: 10.2169/internalmedicine.55.5569.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.55.5569</ArticleId><ArticleId IdType="pubmed">26984092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li J., Lu H., Liu Y. A de novo c.1509dupA:p.R503fs mutation of FUS: Report of a girl with sporadic juvenile amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2020;21:635&#x2013;637. doi: 10.1080/21678421.2020.1775256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1775256</ArticleId><ArticleId IdType="pubmed">32501131</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd K.C., Power R., Ealing J., Hamdalla H. FUS-ALS presenting with myoclonic jerks in a 17-year-old man. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2019;20:278&#x2013;280. doi: 10.1080/21678421.2019.1582665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1582665</ArticleId><ArticleId IdType="pubmed">30879340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Wang H., Cai Y., Wen H., Wang L., Zhu M., Chen Y., Yu Y., Lu X., Zhou M., et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav. 2020;10:e01625. doi: 10.1002/brb3.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1625</ArticleId><ArticleId IdType="pmc">PMC7303404</ArticleId><ArticleId IdType="pubmed">32307925</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Potocki L., Collier T.R., Woodbury S.L., Adesina A.M., Jones J., Lotze T.E. Utility of whole exome sequencing in evaluation of juvenile motor neuron disease. Muscle Nerve. 2016;53:648&#x2013;652. doi: 10.1002/mus.25030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25030</ArticleId><ArticleId IdType="pubmed">26788680</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C.S., Webber A., Gan-Or Z., Moore F., Dagher A., Dion P.A., Rouleau G.A. De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol. Genet. 2016;2:e63. doi: 10.1212/NXG.0000000000000063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000063</ArticleId><ArticleId IdType="pmc">PMC4830191</ArticleId><ArticleId IdType="pubmed">27123482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Zhao Z., Shen H., Bing Q., Li N., Hu J. Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation. Med. Sci. Monit. 2018;24:8750&#x2013;8757. doi: 10.12659/MSM.913724.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.913724</ArticleId><ArticleId IdType="pmc">PMC6289031</ArticleId><ArticleId IdType="pubmed">30507891</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumer D., Hilton D., Paine S.M., Turner M.R., Lowe J., Talbot K., Ansorge O. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611&#x2013;618. doi: 10.1212/WNL.0b013e3181ed9cde.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ed9cde</ArticleId><ArticleId IdType="pmc">PMC2931770</ArticleId><ArticleId IdType="pubmed">20668261</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.C., Baker M., Stewart H., Eisen A., Rademakers R., et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., Servidei S., Trombetta F., Sabatelli M. P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.08.003</ArticleId><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Liu M.S., Li X.G., Cui L.Y. Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression. Ann. Transl. Med. 2015;3:221. doi: 10.3978/j.issn.2305-5839.2015.09.04.</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2305-5839.2015.09.04</ArticleId><ArticleId IdType="pmc">PMC4583590</ArticleId><ArticleId IdType="pubmed">26488017</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C., Patankar A., Amaya J., Watts J.A., Li D., Ramirez P., Schindler A.B., Fischbeck K.H., Cheung V.G. Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4. Ann. Neurol. 2020;87:547&#x2013;555. doi: 10.1002/ana.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25681</ArticleId><ArticleId IdType="pmc">PMC7818251</ArticleId><ArticleId IdType="pubmed">31957062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chance P.F., Rabin B.A., Ryan S.G., Ding Y., Scavina M., Crain B., Griffin J.W., Cornblath D.R. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet. 1998;62:633&#x2013;640. doi: 10.1086/301769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/301769</ArticleId><ArticleId IdType="pmc">PMC1376963</ArticleId><ArticleId IdType="pubmed">9497266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am. J. Hum. Genet. 2004;74:1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin B.A., Griffin J.W., Crain B.J., Scavina M., Chance P.F., Cornblath D.R. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain. 1999;122:1539&#x2013;1550. doi: 10.1093/brain/122.8.1539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/122.8.1539</ArticleId><ArticleId IdType="pubmed">10430837</ArticleId></ArticleIdList></Reference><Reference><Citation>Algahtani H., Shirah B., Algahtani R., Naseer M.I., Al-Qahtani M.H., Abdulkareem A.A. Ataxia with ocular apraxia type 2 not responding to 4-aminopyridine: A rare mutation in the SETX gene in a Saudi patient. Intractable Rare Dis. Res. 2018;7:275&#x2013;279. doi: 10.5582/irdr.2018.01107.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2018.01107</ArticleId><ArticleId IdType="pmc">PMC6290838</ArticleId><ArticleId IdType="pubmed">30560021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanetti L., Cavalieri S., Pensato V., Erbetta A., Pareyson D., Panzeri M., Zorzi G., Antozzi C., Moroni I., Gellera C., et al. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum &#x3b1;-fetoprotein. Orphanet J. Rare Dis. 2013;8:123. doi: 10.1186/1750-1172-8-123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-8-123</ArticleId><ArticleId IdType="pmc">PMC3751478</ArticleId><ArticleId IdType="pubmed">23941260</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard P., Feng S., Tsai Y.L., Li W., Rinchetti P., Muhith U., Irizarry-Cole J., Stolz K., Sanz L.A., Hartono S., et al. SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation. Autophagy. 2021;17:1889&#x2013;1906. doi: 10.1080/15548627.2020.1796292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1796292</ArticleId><ArticleId IdType="pmc">PMC8386630</ArticleId><ArticleId IdType="pubmed">32686621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner N.K., Linder P. DExD/H box RNA helicases: From generic motors to specific dissociation functions. Mol. Cell. 2001;8:251&#x2013;262. doi: 10.1016/S1097-2765(01)00329-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00329-X</ArticleId><ArticleId IdType="pubmed">11545728</ArticleId></ArticleIdList></Reference><Reference><Citation>Skourti-Stathaki K., Proudfoot N.J., Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol. Cell. 2011;42:794&#x2013;805. doi: 10.1016/j.molcel.2011.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.04.026</ArticleId><ArticleId IdType="pmc">PMC3145960</ArticleId><ArticleId IdType="pubmed">21700224</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzu A., Bermejo R., Begnis M., Lucca C., Piccini D., Carotenuto W., Saponaro M., Brambati A., Cocito A., Foiani M., et al. Senataxin associates with replication forks to protect fork integrity across RNA-polymerase-II-transcribed genes. Cell. 2012;151:835&#x2013;846. doi: 10.1016/j.cell.2012.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.09.041</ArticleId><ArticleId IdType="pmc">PMC3494831</ArticleId><ArticleId IdType="pubmed">23141540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S., Puget N., Lin Y.L., Clouaire T., Aguirrebengoa M., Rocher V., Pasero P., Canitrot Y., Legube G. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nat. Commun. 2018;9:533. doi: 10.1038/s41467-018-02894-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-02894-w</ArticleId><ArticleId IdType="pmc">PMC5803260</ArticleId><ArticleId IdType="pubmed">29416069</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C., Wang I.X., Watts J.A., Burdick J.T., Guber R.D., Zhu Z., Bruzel A., Lanman T., Chen K., Schindler A.B., et al. Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters. Mol. Cell. 2018;69:426&#x2013;437.e427. doi: 10.1016/j.molcel.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., Hung W.Y., Figlewicz D.A., Haines J., Rimmler J., Ben Hamida C., et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat. Genet. 1994;7:425&#x2013;428. doi: 10.1038/ng0794-425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0794-425</ArticleId><ArticleId IdType="pubmed">7920663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Hamida M., Hentati F., Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain. 1990;113:347&#x2013;363. doi: 10.1093/brain/113.2.347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/113.2.347</ArticleId><ArticleId IdType="pubmed">2328408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress J.A., Kuhnlein P., Winter P., Ludolph A.C., Kassubek J., Muller U., Sperfeld A.D. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2005;58:800&#x2013;803. doi: 10.1002/ana.20665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20665</ArticleId><ArticleId IdType="pubmed">16240357</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi S., Foo J.N., Vu A., Azim S., Silver D.L., Mansoor A., Tay S.K., Abbasi S., Hashmi A.H., Janjua J., et al. A novel splice-site mutation in ALS2 establishes the diagnosis of juvenile amyotrophic lateral sclerosis in a family with early onset anarthria and generalized dystonias. PLoS ONE. 2014;9:e113258. doi: 10.1371/journal.pone.0113258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113258</ArticleId><ArticleId IdType="pmc">PMC4256290</ArticleId><ArticleId IdType="pubmed">25474699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprute R., Jergas H., Olmez A., Alawbathani S., Karasoy H., Dafsari H.S., Becker K., Daimaguler H.S., Nurnberg P., Muntoni F., et al. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations. Am. J. Med. Genet. A. 2021;185:344&#x2013;354. doi: 10.1002/ajmg.a.61951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.61951</ArticleId><ArticleId IdType="pubmed">33155358</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymard-Pierre E., Lesca G., Dollet S., Santorelli F.M., di Capua M., Bertini E., Boespflug-Tanguy O. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am. J. Hum. Genet. 2002;71:518&#x2013;527. doi: 10.1086/342359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342359</ArticleId><ArticleId IdType="pmc">PMC379189</ArticleId><ArticleId IdType="pubmed">12145748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheerin U.M., Schneider S.A., Carr L., Deuschl G., Hopfner F., Stamelou M., Wood N.W., Bhatia K.P. ALS2 mutations: Juvenile amyotrophic lateral sclerosis and generalized dystonia. Neurology. 2014;82:1065&#x2013;1067. doi: 10.1212/WNL.0000000000000254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000254</ArticleId><ArticleId IdType="pmc">PMC3962990</ArticleId><ArticleId IdType="pubmed">24562058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Vande Velde C., Eymard-Pierre E., Bertini E., Boespflug-Tanguy O., Cleveland D.W. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc. Natl. Acad. Sci. USA. 2003;100:16041&#x2013;16046. doi: 10.1073/pnas.2635267100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2635267100</ArticleId><ArticleId IdType="pmc">PMC307689</ArticleId><ArticleId IdType="pubmed">14668431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., Hung W.Y., Ouahchi K., Yan J., Azim A.C., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 2001;29:160&#x2013;165. doi: 10.1038/ng1001-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-160</ArticleId><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Nichol K., Brinkman R.R., Nasir J., Martindale D., Koop B.F., Nicholson D.W., Scherer S.W., Ikeda J.E., Hayden M.R. A yeast artificial chromosome-based physical map of the juvenile amyotrophic lateral sclerosis (ALS2) critical region on human chromosome 2q33-q34. Genomics. 1999;55:106&#x2013;112. doi: 10.1006/geno.1998.5637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1998.5637</ArticleId><ArticleId IdType="pubmed">9889004</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A., Hadano S., Okada T., Mizumura H., Kunita R., Nishijima H., Showguchi-Miyata J., Yanagisawa Y., Kohiki E., Suga E., et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 2003;12:1671&#x2013;1687. doi: 10.1093/hmg/ddg184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg184</ArticleId><ArticleId IdType="pubmed">12837691</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp J.D., Gray N.W., Gerard R.D., Horazdovsky B.F. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J. Biol. Chem. 2004;279:24612&#x2013;24623. doi: 10.1074/jbc.M313504200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M313504200</ArticleId><ArticleId IdType="pubmed">15033976</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano I., Murakami T., Shiote M., Manabe Y., Hadano S., Yanagisawa Y., Ikeda J.E., Abe K. Single-nucleotide polymorphisms in uncoding regions of ALS2 gene of Japanese patients with autosomal-recessive amyotrophic lateral sclerosis. Neurol. Res. 2003;25:505&#x2013;509. doi: 10.1179/016164103101201733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164103101201733</ArticleId><ArticleId IdType="pubmed">12866199</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S., Mancias P., Kiyama H., Yamanaka K. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437. doi: 10.15252/emmm.201606403.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah M.I., Ahmad A., Raza S.I., Amar A., Ali A., Bhatti A., John P., Mohyuddin A., Ahmad W., Hassan M.J. In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia. Neurogenetics. 2015;16:299&#x2013;306. doi: 10.1007/s10048-015-0453-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-015-0453-1</ArticleId><ArticleId IdType="pubmed">26205306</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Hu Z., Liu L., Xie Y., Zhan Y., Zi X., Wang J., Wu L., Xia K., Tang B., et al. A SIGMAR1 splice-site mutation causes distal hereditary motor neuropathy. Neurology. 2015;84:2430&#x2013;2437. doi: 10.1212/WNL.0000000000001680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001680</ArticleId><ArticleId IdType="pubmed">26078401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov T.A., Epstein M.L., Andersen K.A., Ziskind-Conhaim L., Ruoho A.E. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience. 2010;167:247&#x2013;255. doi: 10.1016/j.neuroscience.2010.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.022</ArticleId><ArticleId IdType="pmc">PMC2862368</ArticleId><ArticleId IdType="pubmed">20167253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata J., Shimohama S., Takano S., Harada K., Ueda K., Kimura J. Novel G16S (GGC-AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum. Mutat. 1997;9:356&#x2013;358. doi: 10.1002/(SICI)1098-1004(1997)9:4&lt;356::AID-HUMU9&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1004(1997)9:4&lt;356::AID-HUMU9&gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">9101297</ArticleId></ArticleIdList></Reference><Reference><Citation>Keckarevic D., Stevic Z., Keckarevic-Markovic M., Kecmanovic M., Romac S. A novel P66S mutation in exon 3 of the SOD1 gene with early onset and rapid progression. Amyotroph. Lateral Scler. 2012;13:237&#x2013;240. doi: 10.3109/17482968.2011.627588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.627588</ArticleId><ArticleId IdType="pubmed">22214314</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M.D., Traynor B.J., Miller N., Corr B., Frost E., McQuaid S., Brett F.M., Green A., Hardiman O. &#x201c;True&#x201d; sporadic ALS associated with a novel SOD-1 mutation. Ann. Neurol. 2002;52:680&#x2013;683. doi: 10.1002/ana.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10369</ArticleId><ArticleId IdType="pubmed">12402272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Chia R., Miller D.E., Li R., Kumaran R., Abramzon Y., Alahmady N., Renton A.E., Topp S.D., Gibbs J.R., et al. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. JAMA Neurol. 2021 doi: 10.1001/jamaneurol.2021.2598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2598</ArticleId><ArticleId IdType="pmc">PMC8406220</ArticleId><ArticleId IdType="pubmed">34459874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P., Donkervoort S., Lone M.A., Nalls M., Gable K., Gupta S.D., Foley A.R., Hu Y., Saute J.A.M., Moreira A.L., et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat. Med. 2021;27:1197&#x2013;1204. doi: 10.1038/s41591-021-01346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01346-1</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Zhou S., Noreau A., Sabbagh M., Belzil V., Dionne-Laporte A., Tranchant C., Dion P., Rouleau G.A. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol. Aging. 2012;33:e835&#x2013;e839. doi: 10.1016/j.neurobiolaging.2011.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.012</ArticleId><ArticleId IdType="pubmed">22154821</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozner T., Regensburger M., Engelhorn T., Winkler J., Winner B. Janus-faced spatacsin (SPG11): Involvement in neurodevelopment and multisystem neurodegeneration. Brain. 2020;143:2369&#x2013;2379. doi: 10.1093/brain/awaa099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa099</ArticleId><ArticleId IdType="pmc">PMC7447516</ArticleId><ArticleId IdType="pubmed">32355960</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed A.C., McDonough B., Gouvion C.M., Newell K.L., Dure L.S., Bebin M., Bick A.G., Seidman J.G., Harter D.H., Seidman C.E. UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration. Ann. Neurol. 2014;75:793&#x2013;798. doi: 10.1002/ana.24164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24164</ArticleId><ArticleId IdType="pmc">PMC4106259</ArticleId><ArticleId IdType="pubmed">24771548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunca C., Akcimen F., Coskun C., Gundogdu-Eken A., Kocoglu C., Cevik B., Bekircan-Kurt C.E., Tan E., Basak A.N. ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur. J. Hum. Genet. 2018;26:745&#x2013;748. doi: 10.1038/s41431-018-0107-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0107-5</ArticleId><ArticleId IdType="pmc">PMC5945623</ArticleId><ArticleId IdType="pubmed">29453415</ArticleId></ArticleIdList></Reference><Reference><Citation>Alazami A.M., Adly N., Al Dhalaan H., Alkuraya F.S. A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18) Neurogenetics. 2011;12:333&#x2013;336. doi: 10.1007/s10048-011-0291-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-011-0291-8</ArticleId><ArticleId IdType="pmc">PMC3215864</ArticleId><ArticleId IdType="pubmed">21796390</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroglu C., Yilmaz R., Sorgun M.H., Solakoglu S., Sener O. GNE missense mutation in recessive familial amyotrophic lateral sclerosis. Neurogenetics. 2017;18:237&#x2013;243. doi: 10.1007/s10048-017-0527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-017-0527-3</ArticleId><ArticleId IdType="pubmed">29086072</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo N., Malicdan M.C., Huizing M. GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges. Neurotherapeutics. 2018;15:900&#x2013;914. doi: 10.1007/s13311-018-0671-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0671-y</ArticleId><ArticleId IdType="pmc">PMC6277305</ArticleId><ArticleId IdType="pubmed">30338442</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms M.M., Miller T.M., Baloh R.H. TARDBP-Related Amyotrophic Lateral Sclerosis. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Mirzaa G., Amemiya A., editors. GeneReviews((R)) GeneReviews&#xae; [Internet]; Seattle, WA, USA: 1993.</Citation></Reference><Reference><Citation>Yamaura G., Higashiyama Y., Kusama K., Kunii M., Tanaka K., Koyano S., Nakashima M., Tsurusaki Y., Miyake N., Saitsu H., et al. Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease. Intern. Med. 2019;58:2715&#x2013;2719. doi: 10.2169/internalmedicine.2126-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.2126-18</ArticleId><ArticleId IdType="pmc">PMC6794182</ArticleId><ArticleId IdType="pubmed">31178479</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.P., Soeiro E.S.M., Silveira F., Pinto S., Gromicho M., Sousa A.B., Leao M., De Carvalho M. VRK1 variants in two Portuguese unrelated patients with childhood-onset motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2020;21:291&#x2013;295. doi: 10.1080/21678421.2020.1746343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1746343</ArticleId><ArticleId IdType="pubmed">32242460</ArticleId></ArticleIdList></Reference><Reference><Citation>Renbaum P., Kellerman E., Jaron R., Geiger D., Segel R., Lee M., King M.C., Levy-Lahad E. Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. Am. J. Hum. Genet. 2009;85:281&#x2013;289. doi: 10.1016/j.ajhg.2009.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.07.006</ArticleId><ArticleId IdType="pmc">PMC2725266</ArticleId><ArticleId IdType="pubmed">19646678</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Takahashi Y., Matsukawa T., Toda T., Tsuji S. Juvenile amyotrophic lateral sclerosis with complex phenotypes associated with novel SYNE1 mutations. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2020:11&#x2013;13. doi: 10.1080/21678421.2020.1813312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1813312</ArticleId><ArticleId IdType="pubmed">32870032</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadaf S.N., Chakor R.T., Kothari K.V., Mannan A.U. Synaptic Nuclear Envelope Protein 1 (SYNE 1) Ataxia with Amyotrophic Lateral Sclerosis-like Presentation: A Novel Synaptic Nuclear Envelope Protein 1 (SYNE 1) Gene Deletion Mutation from India. Ann. Indian Acad. Neurol. 2020;23:539&#x2013;541. doi: 10.4103/aian.AIAN_448_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aian.AIAN_448_18</ArticleId><ArticleId IdType="pmc">PMC7657298</ArticleId><ArticleId IdType="pubmed">33223674</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X., Hao Y., Cao Z., Zhou C., Zhang J., Wang R., Sun S., Gu W. Autosomal Recessive Cerebellar Ataxia Type 1: Phenotypic and Genetic Correlation in a Cohort of Chinese Patients with SYNE1 Variants. Cerebellum. 2021;20:74&#x2013;82. doi: 10.1007/s12311-020-01186-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-020-01186-8</ArticleId><ArticleId IdType="pubmed">32889669</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Fan D. A novel mutation of BICD2 gene associated with juvenile amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2017;18:454&#x2013;456. doi: 10.1080/21678421.2017.1304557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1304557</ArticleId><ArticleId IdType="pubmed">28335620</ArticleId></ArticleIdList></Reference><Reference><Citation>Koboldt D.C., Waldrop M.A., Wilson R.K., Flanigan K.M. The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular Atrophy. Ann. Neurol. 2020;87:487&#x2013;496. doi: 10.1002/ana.25704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25704</ArticleId><ArticleId IdType="pubmed">32057122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Fan D. A Novel Missense Mutation of the DDHD1 Gene Associated with Juvenile Amyotrophic Lateral Sclerosis. Front. Aging Neurosci. 2016;8:291. doi: 10.3389/fnagi.2016.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00291</ArticleId><ArticleId IdType="pmc">PMC5138217</ArticleId><ArticleId IdType="pubmed">27999540</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuurs-Hoeijmakers J.H., Geraghty M.T., Kamsteeg E.J., Ben-Salem S., de Bot S.T., Nijhof B., van de V., II, van der Graaf M., Nobau A.C., Otte-Holler I., et al. Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am. J. Hum. Genet. 2012;91:1073&#x2013;1081. doi: 10.1016/j.ajhg.2012.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.10.017</ArticleId><ArticleId IdType="pmc">PMC3516595</ArticleId><ArticleId IdType="pubmed">23176823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Liao Y.H., Ionita C., Bale A.E., Darras B., Acsadi G. Mitochondrial Membrane Protein-Associated Neurodegeneration Mimicking Juvenile Amyotrophic Lateral Sclerosis. Pediatr. Neurol. 2016;64:83&#x2013;86. doi: 10.1016/j.pediatrneurol.2016.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2016.08.013</ArticleId><ArticleId IdType="pubmed">27671242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>